The American Journal of Managed Care

JAK Inhibitors Show Promise in Alopecia But Long-Term Management Requires More Study: Maria Hordinsky, MD

Janus kinase (JAK) inhibitors are a promising and new method of treating alopecia areata, giving doctors new options for ...
Dermatology Advisor

Switching Between JAK Inhibitors Can be Effective in Severe Alopecia Areata

Patients with alopecia areata who did not respond to initial treatment with a JAKi or who did not maintain response may ...
The American Journal of Managed Care

Noteworthy Studies on JAK Inhibitors, Skin-Gut Relationship in Alopecia Areata: Maria Hordinsky, MD

Maria Hordinsky, MD, discusses exciting results in alopecia areata, including some discussed at the Winter Clinical ...
Medscape

UK Approves New JAK Inhibitor for Severe Alopecia

Deuruxolitinib is the latest JAK inhibitor to enter the UK alopecia areata treatment landscape, pending a NICE decision on ...
Healio

More JAK inhibitors ‘coming down the pike’ despite poor understanding of mechanism

Please provide your email address to receive an email when new articles are posted on . The pipeline of Janus kinase inhibitors is robust even as researchers struggle to fully understand how they work ...
Mena FN

Janus Kinase (JAK) 3 Inhibitor Industry Analysis: Market Competition And Outlook

(MENAFN- EIN Presswire) EINPresswire/ -- The janus kinase (JAK) 3 inhibitor market has been witnessing significant growth recently, driven by advancements in medical research and an increasing focus ...
Medical News Today

JAK2 gene: Function, conditions, and research

The JAK2 gene is a protein-coding gene of the Janus kinase family. It plays a role in cellular signaling. Evidence notes connections between this gene and some medical conditions. Variations in this ...